Sharon Lam

Title: Innovations in HIV Immunotherapy by Sharon Lam

Introduction

Sharon Lam is a prominent inventor based in Atlanta, GA, who has made significant contributions to the field of immunotherapy, particularly in the fight against HIV. With a focus on developing innovative solutions, she has been instrumental in advancing therapeutic strategies that target HIV effectively.

Latest Patents

Sharon Lam holds a patent for the "Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic use." This patent encompasses compositions for T cell-based immunotherapy aimed at treating HIV, HIV-associated malignancies, and other related complications. Her work includes the development of modified T cells that are resistant to HIV infection, specifically T-cells that have been altered to reduce or eliminate the expression of the mannosyl-oligosaccharide glucosidase enzyme (MOGS). Additionally, she has outlined methods for producing these compositions by expanding HIV-specific T cells from various sources to recognize multiple HIV antigens.

Career Highlights

Sharon Lam is affiliated with the Children's National Medical Center, where she collaborates with a team of dedicated professionals. Her innovative research has positioned her as a key figure in the development of new therapeutic approaches to combat HIV.

Collaborations

Sharon has worked alongside notable colleagues, including Catherine M Bollard and Conrad Russell Y Cruz, contributing to a collaborative environment that fosters groundbreaking research in immunotherapy.

Conclusion

Sharon Lam's work in HIV immunotherapy exemplifies the impact of innovative research on public health. Her contributions continue to pave the way for advancements in treatment options for those affected by HIV.